Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.22 | N/A | +3.77% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.22 | N/A | +3.77% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautiously optimistic outlook, emphasizing their focus on product development and market expansion.
Management highlighted strong performance in key product segments.
They expressed confidence in ongoing innovation and market demand.
Boston Scientific's earnings report shows a positive surprise in EPS, which contributed to a 2.12% increase in stock price. The company's management highlighted strong performance in key areas, indicating a solid foundation for future growth. However, the lack of revenue data and guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
FABRINET
Feb 2, 2015